Half of Workers May Have Difficulty Obtaining Obesity Drug Insurance Coverage
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…
Eli Lilly and company
Wells Fargo CEO Talks Reasons to Love Stocks, Plus Why the Market is Falling
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Ro launches GLP-1 supply tracker to help patients overcome shortages
Zoom in iconArrows pointing outwards Telehealth company Ro on Wednesday launched a new tracker to help patients find a popular…
Eli Lilly invests to increase Mounjaro and Zepbound offering
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is displayed in New York City, U.S., on December 11,…
This promising cancer treatment could represent a $25 billion market opportunity
Skynesher | E+ | fake images Big Pharma is betting billions on a promising class of cancer treatments that some…
Stocks set to move as this corner of the cancer therapy market heats up
Much attention has been paid lately to a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy…
Eli Lilly and Novo Nordisk develop weekly insulin
A patient injects herself with an insulin pen. Guido Krzikowski | Bloomberg | fake images Do you think a friend…
Eli Lilly shares hit new highs after a regulatory victory in China. This is a big problem
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
AstraZeneca will increase its revenues and launch new drugs by 2030
Astrazeneca's logo appears at the 2021 World Artificial Intelligence Conference in Shanghai, China on July 7, 2021. Costofoto | Future…
Roche's weight-loss drug shows promising results in early trial
A logo at the headquarters of Roche Holding AG in Basel, Switzerland, Thursday, February 1, 2024. Bloomberg | fake images…